Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Parsa Kiai is Director at Medifast. OQRO lists 3 transactions filed with the SEC under this name, the latest on Nov 6, 2026, each linked to the official Form 4.
Director
Disclosures on record
3
Companies involved
1
3 buys, median −3.0 pts vs S&P 500, beat it 0 of 3 times.
Average −2.8 pts vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Aug 21, 2026 to Aug 28, 2026, measured from the first close after the filing. No purchase has reached 90 days yet, so 30 days is shown. Past results, not a forecast.
5 purchases disclosed. $1,000 placed after each of the 5 purchases disclosed since 2025-11-14 would be worth $5.2K today ($5K put in); the same in the S&P 500 (SPY): $5K.
Not ranked: fewer than 10 purchases measured at 90 days. The middle of the 82 ranked insiders is −5.5 pts (median, against the S&P 500).
Equal weight counts every purchase once; by size counts it for its disclosed dollars. Both are measured from the first close after it was reported. Past results describe the past, not a forecast. How this is measured · Leaderboard
MedifastMED
3 disclosures · Oct 2026 – Nov 2026 · 3 bought
Nov 4, 2026Bought~$8.6Kdisclosed Nov 6
DetailsOfficial recordOct 28, 2026Bought~$66Kdisclosed Oct 30
DetailsOct 28, 2026Bought~$1.9Kdisclosed Oct 30
DetailsOfficial recordAs of the latest filing on , Parsa Kiai reported holding 40,406 shares of Medifast (MED), worth about $524K at the last close of $13 (Nov 13, 2026): 19,317 held directly and 21,089 through a notes. In the last 12 months, Parsa Kiai bought $77K in 3 open-market purchases.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Medifast MED | 40,406 | 19K direct · 21K notes | $13 | $524K | Nov 4, 2026 |
Is this Parsa Kiai’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Parsa Kiai bought shares on the open market in 2020, 2022 and 2026 across 2 companies. Sales in 1 of the 7 years since 2020.
Parsa Kiai reported 24 open-market purchases and 2 sales since 2020; purchases in 3 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $77K3×3 trades | — |
| 2023 | — | $31K2×2 trades |
| 2022 | $82K17×17 trades | — |
| 2020 | $64K4×4 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Nov 4, 2026, Parsa Kiai reported holding 40,406 shares of Medifast (MED), of which 21,089 are held indirectly. At the last close of $13 on Nov 13, 2026, that is about $524K. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Parsa Kiai reported 3 open-market purchases worth $77K, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Parsa Kiai bought shares on the open market in 2020, 2022 and 2026 across 2 companies. Sales in 1 of the 7 years since 2020.
In SEC filings since 2020: the latest open-market purchase is from 2026; the latest open-market sale is from 2023.
2 companies: Medifast (MED, 2026), Wheeler Real Estate Investment Trust (WHLR, 2020–2023).
Parsa Kiai reported 21 open-market purchases and 2 sales here, 2020 to 2023.
Parsa Kiai reported 3 open-market purchases and 0 sales here, 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
